As much as people are justifiably excited about the prospect for orally available drugs that can prevent and treat Covid-19, I believe the FDA needs to tread very carefully with molnupiravir, the antiviral currently before them for approval.
Supercharging New Viral Variants: The Dangers Of Molnupiravir (Part 1)
